Zentalis Pharmaceuticals, Inc.(ZNTL)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
ZNTL is scheduled to report on Nov 9, 2026, usually after the market closes. Analysts expect EPS of -$0.55.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±9.6%).
Did the stock rise after good news?
The next-day move after each of its last 8 EPS beats and 4 misses.
In plain words: it beat expectations 8 times, but the stock still fell 3 of those 8 times.
- Aug '26Missed▼ -15.6%
- Mar '26Beat▼ -21.3%
- Nov '25Beat▲ +6.1%
- Aug '25Beat▲ +5.1%
- May '25Missed▲ +5.9%
- Mar '25Beat▼ -5.9%
- Nov '24Beat▲ +5.7%
- Aug '24Missed▼ -9.4%
- May '24Beat▲ +5.0%
- Feb '24Beat▲ +4.5%
- Nov '23Beat▼ -30.2%
- Aug '23Missed▲ +0.7%
Clear beats and misses with a known reaction only. What counts as a beat
Why did ZNTL fall after beating earnings?
5 of ZNTL's last 12 reactions went against the EPS result. What stands out in each:
ZNTL beat EPS estimates in 8 quarters, and the stock still closed lower the next day 3 times. In 3 of the 3 where we have price data, the stock had already run up before the report.
- Mar 26, 2026EPS beat +19.7%stock -21.3% next day
- It had risen 8.1% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 2.6% lower as soon as trading resumed.
- Mar 25, 2025EPS beat +10.3%stock -5.9% next day
- It had risen 5.6% in the final week before the report, so good news may already have been priced in.
- It opened 1.1% lower as soon as trading resumed.
- Nov 6, 2023EPS beat +16.0%stock -30.2% next day
- It had risen 10.4% in the final week before the report, so good news may already have been priced in.
Rose despite an EPS miss (2 of 4)
- May 14, 2025EPS missed -9.8%stock +5.9% next day
- It had already fallen 6.3% in the 20 trading sessions before the report, so weak results may have been expected.
- It opened 4.2% higher as soon as trading resumed.
- Aug 9, 2023EPS missed -81.4%stock +0.7% next day
- It had already fallen 7.1% in the 20 trading sessions before the report, so weak results may have been expected.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was ZNTL's earnings move already priced in?
ZNTL's move in the month before each of its last 12 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 12 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does ZNTL hold its opening gap after earnings?
ZNTL's opening move after each report and where it closed that day.
In 10 reports ZNTL opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 10 times (20%), and fully reversed 2 times. Gaps up faded 0 of 4; gaps down recovered 2 of 6.
- Aug 6, 2026HeldOpened -6.4%, closed -15.6%
- Mar 26, 2026HeldOpened -2.6%, closed -21.3%
- Nov 10, 2025ReversedOpened -5.3%, closed +6.1%
- May 14, 2025HeldOpened +4.2%, closed +5.9%
- Mar 25, 2025HeldOpened -1.1%, closed -5.9%
- Nov 12, 2024HeldOpened +10.0%, closed +5.7%
- Aug 9, 2024HeldOpened -9.4%, closed -9.4%
- May 7, 2024HeldOpened +6.1%, closed +5.0%
ZNTL earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Aug 6, 2026 | After close | -$0.48 | -$0.59 | -22.9% | -15.60% | -17.80% |
| Mar 26, 2026 | After close | -$0.61 | -$0.49 | +19.7% | -21.35% | -12.36% |
| Nov 10, 2025 | After close | -$0.48 | -$0.37 | +22.9% | +6.06% | 0.00% |
| Aug 6, 2025 | After close | -$0.52 | -$0.37 | +28.8% | +5.07% | +1.45% |
| May 14, 2025 | After close | -$0.61 | -$0.67 | -9.8% | +5.88% | +5.04% |
| Mar 25, 2025 | After close | -$0.68 | -$0.61 | +10.3% | -5.88% | -3.21% |
| Nov 12, 2024 | After close | -$0.87 | -$0.56 | +35.6% | +5.66% | -6.47% |
| Aug 9, 2024 | Before open | -$0.83 | -$1.24 | -49.4% | -9.37% | -8.46% |
| May 7, 2024 | Before open | -$0.74 | $0.14 | +118.9% | +5.03% | +6.83% |
| Feb 27, 2024 | Before open | -$0.84 | -$0.83 | +1.2% | +4.47% | +5.89% |
| Nov 6, 2023 | Before open | -$0.94 | -$0.79 | +16.0% | -30.20% | -44.07% |
| Aug 9, 2023 | Before open | -$1.02 | -$1.85 | -81.4% | +0.71% | +6.54% |
Consensus for the next report: EPS -$0.55, revenue $0.00.
ZNTL Earnings FAQ
Answers computed from Zentalis Pharmaceuticals, Inc.'s reported history
ZNTL is scheduled to report on Nov 9, 2026, usually after the market closes. Analysts expect EPS of -$0.55.
Over the last 12 quarters with a usable EPS surprise, ZNTL beat the consensus estimate 8 times (67%), missed 4 and landed in line 0.
Across its last 12 quarters with a measured reaction, ZNTL moved an average of ±9.6% in the first session after reporting. It closed higher 58% of the time; the largest gain was 6.1% and the largest drop -30.2%.
ZNTL fell in the first session after 3 of its last 8 EPS beats (38%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 3 of the 3 of those falls where price data is available, the stock had already risen before the report.
Across its last 12 quarters with price data, ZNTL moved an average of -2.8% in the 20 trading sessions before reporting and was higher in 42% of them. After a run-up of 3% or more (5 quarters), it fell the next day 40% of the time, averaging -4.3%. After a drop of 3% or more (7 quarters), it rose the next day 57% of the time, averaging -4.0%. This describes past reports; it is not a forecast.
In 10 reports ZNTL opened at least 1% away from the previous close. It gave back half or more of that gap by the close 2 of 10 times (20%), and fully reversed 2 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · ZNTL: 12 reported quarters, latest Aug 6, 2026. Information only, not investment advice.
Looking for more on ZNTL?
Price charts, forecast, fundamentals and risk pages for ZNTL are not on Tickzen yet. You can run a full stock analysis now.
Run the ZNTL Stock AnalyzerLatest TickZen Insights
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun
Coca-Cola (KO) Q3 2026 Earnings Preview: Can Growth Justify Its Valuation?By Vishal Jadaun
Welltower Q3 2026 Earnings Preview: Can 20% Senior Housing Growth Last?By Vishal Jadaun